John Duffin transitions to Chief Strategy and Corporate Development Officer as 3 Boomerang Capital portfolio company continues to expand its capabilities and scale

FISHERS, Ind., Sept. 15, 2026 /PRNewswire/ — Pinnaql, a 3 Boomerang Capital portfolio company and professional services provider delivering consulting and subject matter expertise to pharmaceutical, biotech and medical device organizations, today announced the appointment of Allison Kerska as Chief Executive Officer, effective immediately. John Duffin, who has led Pinnaql through a period of significant growth and transformation, will transition to Chief Strategy and Corporate Development Officer.

The leadership evolution comes at a pivotal point in Pinnaql’s evolution. In less than two years, the company has brought multiple businesses together into an integrated life sciences consulting platform, expanded its geographic presence and broadened its capabilities across engineering, automation, laboratory operations, quality systems, project and program management, CQV/CSV, data integrity and regulatory compliance.

Ms. Kerska brings extensive experience leading and scaling professional services organizations. Most recently, she served as President of ELIQUENT Life Sciences, where she led a GxP consulting and advisory business supporting clients across complex regulatory, quality and operational matters. Previously, she spent more than 15 years in workforce and talent solutions, including senior leadership roles at KellyOCG.

“Pinnaql has reached an exciting inflection point,” said Allison Kerska, Chief Executive Officer of Pinnaql. “John and the team have built an exceptional foundation, bringing together talented people and complementary capabilities around a clear vision for serving life sciences clients. The opportunity now is to scale that platform thoughtfully without losing what makes Pinnaql differentiated: deep expertise, trusted relationships and an ability to make complex challenges easier for our clients.”

Pinnaql’s growth strategy is centered on creating an increasingly comprehensive resource for life sciences organizations. By bringing specialized expertise together within Pinnaql, clients can access engineering, scientific, quality, compliance and digital capabilities through a single trusted partner.

“We have built the foundation, brought together outstanding teams and created a platform with tremendous potential,” said John Duffin, Chief Strategy and Corporate Development Officer of Pinnaql. “Allison has the experience to take what we have built and scale it with the operational discipline this next chapter requires. My new role allows me to remain deeply involved in building and steering Pinnaql’s future, particularly through acquisitions, integration, digital validation and AI.”

The appointment represents the next phase of 3 Boomerang Capital‘s strategy to build Pinnaql into a differentiated and scalable life sciences services platform.

“Pinnaql has made significant progress building an integrated platform in an attractive and resilient segment of the life sciences market,” said Peter Wen, Principal at 3 Boomerang Capital. “Allison brings the operating leadership and professional services experience to drive disciplined growth and realize the value of the capabilities we have unified, while John’s continued focus on M&A and strategic innovation drives the momentum behind the platform. We believe this leadership structure positions Pinnaql well for its next chapter of growth and value creation.”

Under Ms. Kerska’s leadership, Pinnaql will continue advancing its strategy of combining deep technical expertise with a scalable, integrated operating model to support increasingly complex development, commercialization and manufacturing needs across the life sciences sector.

About Pinnaql

Pinnaql is a 3 Boomerang Capital portfolio company and professional services provider delivering consulting and subject matter expertise to pharmaceutical, biotech and medical device organizations. Pinnaql provides integrated expertise across engineering and automation, laboratory operations, quality systems, project and program management, data integrity, commissioning, qualification and validation (CQV), computer system validation (CSV), audit readiness, remediation support and regulatory compliance.

By bringing specialized expertise together, the company helps life sciences organizations navigate complexity, accelerate programs and maintain compliance across the product lifecycle. For more information, please visit https://www.pinnaql.com/.

About 3 Boomerang Capital

3 Boomerang Capital, L.P. is a lower-middle-market healthcare private equity firm committed to fostering creative investment partnerships with healthcare entrepreneurs across North America and Western Europe. 3BC’s areas of investment focus span four key healthcare sectors: biopharma outsourcing, medical device and diagnostic manufacturing, information technology and tech-enabled services, and alternate site care.

The firm specializes in backing founder-led businesses, providing the guidance and resources needed for successful growth and innovation in the healthcare market. By strategically concentrating on four core areas, 3 Boomerang Capital is well-equipped to deliver on its mission of empowering healthcare entrepreneurs and propelling healthcare businesses to new heights. The firm is currently investing out of its flagship fund, 3 Boomerang Capital I, LP, a $376 million investment vehicle. To learn more, please visit https://www.3boomerang.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pinnaql-names-allison-kerska-ceo-as-company-enters-next-phase-of-growth-302877695.html

SOURCE Pinnaql